Recognizing the impact the stigmatization of menstruation has on the lives of women, girls, and people who menstruate, and expressing support for the designation of the month of May as "National Menstrual Health Awareness Month".
H. Res. 1323 is a nonbinding House resolution that recognizes the harms caused by the stigmatization of menstruation and expresses support for designating May as National Menstrual Health Awareness Month. The resolution frames menstrual health as an integral part of overall health and emphasizes that menstruation is a normal biological process that should not be surrounded by shame, taboo, or discrimination.
The resolution calls for broader public education about menstrual health, including instruction for young people on menstrual hygiene management and the physical, mental, and social impacts of menstruation. It also supports improved access to menstrual products, safe and private sanitation facilities, and better information and care for menstrual-related conditions such as dysmenorrhea, fibroids, endometriosis, polycystic ovary syndrome, and menopause. In addition, it highlights the need for more clinical research and health education in women’s health.
Because this is a House resolution, it does not directly amend federal or state law or create enforceable rights or funding requirements. Its practical effect is symbolic and advocacy-oriented: it signals congressional support for menstrual health awareness, encourages schools, workplaces, and health systems to improve access to menstrual products and sanitation, and promotes research and education on menstrual and uterine health conditions. The resolution may also influence public health messaging and future policy discussions at the federal, state, and local levels.
The overall sentiment reflected in the bill text is strongly supportive and affirmative. The resolution is framed around health equity, dignity, and gender equality, and it presents menstrual health awareness as a mainstream public health issue rather than a niche or stigmatized topic. The sponsorship list suggests broad support among Democratic members, and the absence of recorded votes or committee debate in the provided materials indicates no documented opposition in the available record.
The main points of potential contention are not expressed in the text or voting history provided, but the resolution’s emphasis on menstruation education, stigma reduction, and access to menstrual products could draw disagreement from members who view such measures as outside the proper scope of congressional action or who object to related cultural and social messaging. The resolution also references people who menstruate, which may be a point of political sensitivity for some stakeholders. However, no specific objections, amendments, or recorded opposition appear in the supplied committee or vote information.